20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25196 | BZAD01 | BZAD-01,BZAD 01 | NMDAR |
BZAD01 is a selective NMDA NR1A/2B receptor antagonist. | |||
T1186 | Ifenprodil Tartrate | Potassium Channel , NMDAR , iGluR | |
Ifenprodil is a selective NMDA receptor (glutamate) antagonist. | |||
T22674 | Co 101244 hydrochloride | 4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride | NMDAR |
Co 101244 hydrochloride (4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride) is an NR2B-containing NMDA receptor antagonist. | |||
T13112L1 | Tat-NR2B9c acetate | Tat-NR2B9c acetate (500992-11-0 Free base),NA-1 acetate | Others |
Tat-NR2B9c acetate (NA-1 acetate) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c acetate disrupts the PSD-... | |||
T13112 | Tat-NR2B9c | Tat-NR2Bct,NA-1 | NO Synthase , iGluR |
Tat-NR2B9c (NA-1) is a postsynaptic density-95 (PSD-95) inhibitor with neuroprotective and antiepileptic effects.Tat-NR2B9c inhibits PSD-95d2, PSD-95d1, and PSD-95, which prevents the activation of NMDA-induced NADPH oxi... | |||
T81037 | Tat-HA-NR2B9c | ||
Tat-HA-NR2B9, comprising an HIV-1 Tat transduction domain fragment, an influenza virus hemagglutinin (HA) epitope-tag, and the C-terminal 9 amino acids of NR2B (NR2B9c), has demonstrated efficacy in reducing infarct size... | |||
T35924 | Tat-NR2Baa | Tat-NR2Baa | |
Tat-NR2BAA is an inactive control peptide of Tat-NR2B9c. It shares a similar sequence with Tat-NR2B9c, but possesses a double-point mutation in the COOH terminal tSXV motif. This mutation renders Tat-NR2BAA unable to bin... | |||
T76069 | Tat-NR2Baa TFA | ||
Tat-NR2BAA TFA serves as the inactive control peptide for Tat-NR2B9c, featuring a comparable sequence with a crucial distinction: a double-point mutation in its COOH-terminal tSXV motif. This alteration renders Tat-NR2BA... | |||
T13112L | Tat-NR2B9c TFA | NA-1 (TFA) | Others |
Tat-NR2B9c TFA is a 20-aa peptide, and acts as an inhibitor of postsynaptic density-95 (PSD-95)(EC50 of 6.7 nM for PSD-95d2), and possesses neuroprotective efficacy. | |||
T1751 | Eliprodil | SL-820715 | NMDAR , iGluR |
Eliprodil (SL-820715)(SL-820715), a non-competitive NR2B-NMDA receptor antagonist(IC50: 1 uM), less effective for NR2A- and NR2C-containing receptors(IC50> 100 uM). It has been used in trials studying the treatment of Pa... | |||
T5385 | Radiprodil | RGH-896 | NMDAR , iGluR |
Radiprodil (RGH-896) (RGH-896) is an orally active and selective NMDA NR2B receptors antagonist. It was a potential treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPNP). | |||
T12758 | Ro 25-6981 | NMDAR | |
Ro 25-6981 is a potent and selective activity-dependent NMDA receptors blocker containing the NR2B subunit with IC50s of 0.009 and 52 μM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respectively. Ro 2... | |||
T12234 | NMDA-IN-1 | NMDAR | |
NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM). | |||
T23449 | TCS 46b | NMDAR | |
NR1A/NR2B NMDA receptor antagonist,orally active | |||
T8920 | Sepimostat | iGluR | |
Sepimostat exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat dimethanesulfonate inhibits the Ifenprodil binding with a Ki v... | |||
T5522 | NMDAR antagonist 1 | Others , iGluR | |
NMDAR antagonist 1 is an orally active, NR2B-selective NMDAR antagonist. | |||
T8450 | TCN 213 | TCN213 | NMDAR |
TCN 213 is an antagonist of NMDA receptor that has a selective for NR1/NR2A over NR1/NR2B | |||
T23457 | Threo Ifenprodil hemitartrate | Others | |
σ receptor agonist and NR2B subunit-selective NMDA receptor antagonist | |||
T12758L | Ro 25-6981 Maleate | Others | |
Ro 25-6981 Maleate is a potent and selective activity-dependent NMDA receptors blocker containing the NR2B subunit.(IC50 values are 0.009 and 52 μM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respect... | |||
T23239 | Ro 04-5595 hydrochloride | Others | |
NR2B-containing NMDA receptors antagonist |